Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), bought 25,000 shares at $20.00 ($500K) on 2020-07-20, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |